Agnes Kiragga

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV

Nicholas I. Paton, Joseph Musaazi, Cissy Kityo et al. · New England Journal of Medicine · 2021 · 179 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

Nicholas I. Paton, Joseph Musaazi, Cissy Kityo et al. · The Lancet HIV · 2022 · 137 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda

Adelline Twimukye, Miriam Laker, Eva Agnes Laker Odongpiny et al. · BMC Infectious Diseases · 2021 · 41 citations · Full text

Public Health, Health Sciences, Health Services Research +14

COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda

Richard Muhindo, Stephen Okoboi, Agnes Kiragga et al. · PLoS ONE · 2022 · 27 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda

Barbara Castelnuovo, Agnes Kiragga, Joseph Musaazi et al. · PLoS ONE · 2015 · 22 citations · Full text

Pharmacy, Health Sciences, Clinical Pharmacology +13